SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Sees Unusually-High Trading Volume – Should You Buy?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) saw unusually-high trading volume on Tuesday. 248,002 shares traded hands during trading, an increase of 132% from the previous session’s volume of 107,089 shares. The stock last traded at $63.06 and had previously closed at $63.66.

SPDR S&P Pharmaceuticals ETF Stock Performance

The stock has a market cap of $481.26 million, a price-to-earnings ratio of 14.28 and a beta of 0.61. The company has a 50-day moving average of $68.96 and a 200-day moving average of $63.29.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth approximately $26,000. Western Wealth Management LLC purchased a new position in SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at $34,000. Fifth Third Bancorp acquired a new position in SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at $39,000. TD Waterhouse Canada Inc. purchased a new position in SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth $200,000. Finally, Corient Private Wealth LP acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 2nd quarter worth $225,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.